Biogen, Inc. (BIIB)
192.03
-0.05
(-0.03%)
USD |
NASDAQ |
Feb 20, 16:00
191.60
-0.43
(-0.22%)
After-Hours: 20:00
Biogen EPS Diluted (Quarterly) : -0.3333 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Merck & Co., Inc. | 1.191 |
| AbbVie, Inc. | 1.024 |
| Pfizer Inc. | -0.2898 |
| Stoke Therapeutics, Inc. | -0.6543 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.90M |
| Revenue (Quarterly) | 2.181B |
| Total Expenses (Quarterly) | 2.230B |
| Enterprise Value | 31.02B |
| Gross Profit Margin (Quarterly) | 68.12% |
| Profit Margin (Quarterly) | -2.24% |
| Earnings Yield | 4.59% |
| Operating Earnings Yield | 8.59% |
| Normalized Earnings Yield | 6.072 |